The emerging treatment of the medication represents a exciting breakthrough in the care of type 2 diabetes. Unlike existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide317194.blogpostie.com/63255052/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment